Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Entera Bio (ENTX) Tax Provisions (2021 - 2024)

Entera Bio has reported Tax Provisions over the past 4 years, most recently at $14000.0 for Q4 2024.

  • For the quarter ending Q4 2024, Tax Provisions changed N/A year-over-year to $14000.0, compared with a TTM value of $43000.0 through Dec 2024, up 48.28%, and an annual FY2024 reading of $14000.0, down 51.72% over the prior year.
  • Tax Provisions came in at $14000.0 for Q4 2024, down from $29000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $194000.0 in Q3 2022 to a low of -$46000.0 in Q4 2022.
  • Median Tax Provisions over the past 4 years was -$10000.0 (2021), compared with a mean of $12100.0.
  • The largest YoY upside for Tax Provisions was 1592.31% in 2022 against a maximum downside of 206.67% in 2022.
  • Over 4 years, Tax Provisions stood at -$15000.0 in 2021, then crashed by 206.67% to -$46000.0 in 2022, then surged by 163.04% to $29000.0 in 2023, then plummeted by 51.72% to $14000.0 in 2024.
  • Per Business Quant, the three most recent readings for ENTX's Tax Provisions are $14000.0 (Q4 2024), $29000.0 (Q3 2023), and -$46000.0 (Q4 2022).